Denna sida på svenska

Anna Martling

Professor/senior physician

About me

Anna Martling is Professor of Surgery at Karolinska Institutet and a Senior Consultant Colorectal Surgeon at the Center of Digestive Disease, Karolinska University Hospital, Stockholm, Sweden. She defended her thesis on rectal cancer in 2003 and became a board certified surgeon in 2004 and an Associate Professor of Surgery in 2009. Since 2008 she has been research group leader and responsible for the research field of colorectal surgery with special focus on clinical and epidemiological studies on colorectal cancer. A special interest has been radiotherapy, timing of surgery and development of surgical techniques. In 2013 Anna Martling was awarded the Swedish Society of Surgery Major Research Prize. Martling has published more than 60 peer-reviewed articles and is a frequent lecturer in Sweden and abroad.

Since 2013 Anna Martling is the chairman of research at the clinical department. She has several commissions of trust (European Society of Colo Proctology (ESCP), United European Gastroenterology Federation (UEGF), Swedish Cancer Society etc.) and is an assisting Editor of the European Journal of Surgical Oncology, Colorectal Disease and British Journal of Surgery. In 2014 she became Professor of Surgery at the Karolinska Institutet.

Anna Martling's research is funded by the Swedish Research Council, Swedish Cancer Society, Stockholm Cancer Society, the Karolinska Institutet and the Stockholm County Council (ALF). In 2014 she received the Research Council's largest ever contribution to clinical treatment research at MSEK 25.

Research description

Research group leader of the group Colorectal Surgery

Five selected publications:

Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.
Martling A, Holm T, Rutqvist L, Moran B, Heald R, Cedemark B
Lancet 2000 Jul;356(9224):93-6

The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study.
Martling A, Holm T, Johansson H, Rutqvist L, Cedermark B,
Cancer 2001 Aug;92(4):896-902

Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
Martling A, Holm T, Rutqvist L, Johansson H, Moran B, Heald R, et al
Br J Surg 2005 Feb;92(2):225-9

Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression.
Genander M, Halford M, Xu N, Eriksson M, Yu Z, Qiu Z, et al
Cell 2009 Nov;139(4):679-92

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer.
Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, et al
Br J Surg 2010 Apr;97(4):580-7

Links

Videos